Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Plant Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer located in Xining, China, focusing on the extraction and synthesis of plant-based active pharmaceutical ingredients (APIs). The company is a major producer of ephedrine and pseudoephedrine series products, which are essential components in respiratory and cold medications. In addition to its API business, it produces finished drug products across several therapeutic areas, including the central nervous system and cardiovascular health. Operating under the Qinghai Pharmaceutical Group, the company utilizes the natural resources of the Qinghai-Tibet Plateau to maintain a competitive edge in botanical medicine. Its facilities are GMP-certified, supporting its role as a key supplier in both the Chinese and global pharmaceutical supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinghai Plant Pharmaceutical.